Little chance of Teva CEO seeing share price bonus - Globes
Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
Teva Footwear: Who We Are | Teva®
Teva Footwear: Who We Are | Teva®
Teva targets sub-Saharan Africa - Globes
Teva agrees to tentative $4.25 billion national settlement over opioids - The Boston Globe
Teva keeps 2020 guidance unchanged despite virus crisis - Globes
Teva misses on Q3 profit and revenue - Globes
Teva Pharmaceuticals to cut 25 percent of jobs in huge reshaping - The Boston Globe
Teva's new CEO: There's an opportunity to return to growth - Globes
Teva spin-off 89bio files for $70m Wall Street IPO - Globes
New York jury holds drugmaker Teva liable in opioid crisis - The Boston Globe
Teva reaches $225m Texas opioid settlement - Globes
Analysts urge M&A for Teva - Globes
With $40 million pay, Teva breaks from custom for turnaround - The Boston Globe
Amazon.com | Teva Men's Katavi 2 Sandal, Black Olive, 7 | Sport Sandals & Slides
Teva boosted as FDA delays generic Copaxone - Globes
Teva shed 37% of Israel workforce in two years - Globes
Teva: 48 US states agree opioid settlement - Globes
